Vitamin D and inflammatory bowel disease

Area of Science:

• Immunology
• Gastroenterology
• Endocrinology

Background:

• Vitamin D deficiency is an established environmental risk factor for Crohn's disease (CD).
• Low serum 25-hydroxyvitamin D levels correlate with inflammatory bowel disease (IBD) activity.
• Vitamin D's immunoregulatory role extends beyond bone metabolism, influencing immune homeostasis.

Purpose of the Study:

• To explore the multifaceted role of vitamin D in Crohn's disease pathogenesis.
• To review evidence on vitamin D's immunomodulatory functions relevant to IBD.
• To highlight the therapeutic potential of vitamin D and its analogs in IBD.

Main Methods:

• Review of existing literature on vitamin D, VDR, and inflammatory bowel diseases.
• Analysis of studies linking vitamin D status to disease activity and immune responses.
• Examination of genetic associations between VDR variants and Crohn's disease susceptibility.

Main Results:

• Vitamin D interacts with immune cells, affecting proliferation, signaling, and barrier function.
• 1,25-dihydroxyvitamin D influences NOD2-mediated defensin-β2 expression, crucial in CD pathogenesis.
• VDR gene deletion in animal models exacerbates disease severity.
• Genetic variants in the vitamin D receptor (VDR) are candidate susceptibility genes for CD.

Conclusions:

• Vitamin D plays a significant role in immune regulation and intestinal barrier function relevant to Crohn's disease.
• Evidence supports a therapeutic role for vitamin D and VDR agonists in IBD models.
• Further research into vitamin D's impact on IBD pathogenesis and treatment is warranted.